Found: 35
Select item for more details and to access through your institution.
A phase I study of fludarabine, cytarabine, and oxaliplatin therapy in patients with relapsed or refractory acute myeloid leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Penetration of mouse fibroblasts by 2′-deoxyadenosine 5′-phosphate and incorporation of the nucleotide into DNA.
- Published in:
- Journal of Cellular Physiology, 1977, v. 91, n. 2, p. 261, doi. 10.1002/jcp.1040910211
- By:
- Publication type:
- Article
Retinoids and Cancer Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 17, p. 1306
- By:
- Publication type:
- Article
Transport properties of pancreatic cancer describe gemcitabine delivery and response.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 4, p. 1525, doi. 10.1172/JCI73455
- By:
- Publication type:
- Article
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
- Published in:
- 1988
- By:
- Publication type:
- journal article
The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 361, doi. 10.1007/s11912-007-0048-6
- By:
- Publication type:
- Article
Mechanisms of apoptosis induction by nucleoside analogs.
- Published in:
- Oncogene, 2003, v. 22, n. 56, p. 9063, doi. 10.1038/sj.onc.1207229
- By:
- Publication type:
- Article
Complete hematologic and cytogenetic response to 2-amino-9-β-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogeneous leukemia in T-cell blastic phase.
- Published in:
- Cancer (0008543X), 1999, v. 85, n. 1, p. 58, doi. 10.1002/(SICI)1097-0142(19990101)85:1<58::AID-CNCR8>3.0.CO;2-E
- By:
- Publication type:
- Article
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Inhibition of Adenosine Deaminase to Increase the Antitumor Activity of Adenine Nucleoside Analogues.
- Published in:
- Annals of the New York Academy of Sciences, 1985, v. 451, n. 1, p. 150, doi. 10.1111/j.1749-6632.1985.tb27106.x
- By:
- Publication type:
- Article
INCREASED TOXICITY OF 9-β-D-ARABINOFURANOSYLADENINE IN THE PRESENCE OF AN INHIBITOR OF ADENOSINE DEAMINASE *.
- Published in:
- Annals of the New York Academy of Sciences, 1977, v. 284, n. 1, p. 91, doi. 10.1111/j.1749-6632.1977.tb21939.x
- By:
- Publication type:
- Article
THE UTILIZATION OF NUCLEOTIDES BY ANIMAL CELLS<sup>*</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1975, v. 255, n. 1, p. 269, doi. 10.1111/j.1749-6632.1975.tb29235.x
- By:
- Publication type:
- Article
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 323, doi. 10.1007/s10637-009-9369-7
- By:
- Publication type:
- Article
TRIM24 links a non-canonical histone signature to breast cancer.
- Published in:
- Nature, 2010, v. 468, n. 7326, p. 927, doi. 10.1038/nature09542
- By:
- Publication type:
- Article
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.
- Published in:
- Nature Cell Biology, 2012, v. 14, n. 3, p. 276, doi. 10.1038/ncb2432
- By:
- Publication type:
- Article
Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 568, doi. 10.1016/j.clml.2013.03.012
- By:
- Publication type:
- Article
Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 5, p. 1099, doi. 10.1002/cncr.21699
- By:
- Publication type:
- Article
2‐Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 3, p. 541, doi. 10.1002/cncr.21186
- By:
- Publication type:
- Article
The role of clofarabine in hematologic and solid malignancies—Development of a next‐generation nucleoside analog.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 10, p. 1985
- By:
- Publication type:
- Article
Gemcitabine modulation of alkylator therapy.
- Published in:
- Cancer (0008543X), 2001, v. 92, n. 1, p. 194, doi. 10.1002/1097-0142(20010701)92:1<194::AID-CNCR1309>3.0.CO;2-3
- By:
- Publication type:
- Article
Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA101) (iFCG) Treatment for First-Line Therapy of Patients with CLL with Mutated IGHV and Without Deletion 17p.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S13, doi. 10.1016/j.clml.2017.09.041
- By:
- Publication type:
- Article
Repair of DNA damage induced by the novel nucleoside analogue CNDAG through homologous recombination.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 6, p. 559, doi. 10.1007/s00280-004-0916-9
- By:
- Publication type:
- Article
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 5, p. 382, doi. 10.1007/s002800000173
- By:
- Publication type:
- Article
Superoxide dismutase as a target for the selective killing of cancer cells.
- Published in:
- Nature, 2000, v. 407, n. 6802, p. 390, doi. 10.1038/35030140
- By:
- Publication type:
- Article
Mitochonclrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediatecl mechanism.
- Published in:
- Journal of Cell Biology, 2006, v. 175, n. 6, p. 913, doi. 10.1083/jcb.200512100
- By:
- Publication type:
- Article
The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00436-0
- By:
- Publication type:
- Article
Cellular and clinical pharmacology of fludarabine.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Clofarabine, a Second-Generation Nucleoside Analog, in Pediatric Patients With Acute Leukemia.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 11, p. 1309, doi. 10.1177/0091270004269236
- By:
- Publication type:
- Article
Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article